Clinical Trial Update: Drug-drug Interaction Study (CKD-501, Ketoconazole) [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating CKD-501 with ketoconazole; the trial has completed in Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-501
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED